Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, Brűdgam D, Li Q, Song Y, Hu J, Yang S, Satoh F, Ono Y, Libianto R, Stowasser M, Li N, Zhu Q, Hong N, Nayak D, Puar TH, Wu VC, Vaidya A, Araujo-Castro M, Kocjan T, O'Toole SM, Hundemer GL, Ragnarsson O, Lacroix A, Larose S, Nakai K, Nishikawa T, Ladygina D, Turcu AF, Sholinyan J, Fardella CE, Uslar T, Quinkler M, Mulatero P, Pintus G, Rossi GP, Hahner S, Amar L, Drake WM, Varsani C, Brown MJ, Wu X, Deinum J, Freel EM, Kline G, Naruse M, Prejbisz A, Young WF Jr, Williams TA, Fuller PJ.
Yang J, et al. Among authors: li q.
Lancet Diabetes Endocrinol. 2025 Jan 14:S2213-8587(24)00308-5. doi: 10.1016/S2213-8587(24)00308-5. Online ahead of print.
Lancet Diabetes Endocrinol. 2025.
PMID: 39824204